A Clinical Study of MK-4318 and Diltiazem in Healthy People (MK-4318-003)
Clinical trial NCT06692647 · COMPLETED
Trial details
- NCT number
- NCT06692647
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-09
- Primary completion
- 2024-04-11
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.